Skip to content

Omeros OMER Gross margin

Discontinued — last reported Q3 '21

Gross margin at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
100%+31.2pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
67.8%-0.5pp
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
75.3%+12.7pp
Opko Health logo
Opko HealthOPK
36%+4.2pp
Eli Lilly logo
Eli LillyLLY
82.8%+1.1pp

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

Based on trailing twelve months.

The official record: Omeros’s 10-Q, filed November 9, 2021, on SEC EDGAR. View the filing →

Ask your AI about Omeros's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's gross margin?
Omeros (OMER) reported gross margin of 98.9% in Q3 2021.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.